Cargando…

Effects of Thiazolidinedione Therapy on Inflammatory Markers of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Inflammation is a common feature in patients with type 2 diabetes mellitus (T(2)DM). This meta-analysis aimed to assess the influence of thiazolidinedione (TZD) therapy on the circulating levels of inflammatory markers in patients with T(2)DM. METHODS AND RESULTS: We searched the databas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Rui, Yan, Jinchuan, Liu, Peijing, Wang, Zhongqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405205/ https://www.ncbi.nlm.nih.gov/pubmed/25897968 http://dx.doi.org/10.1371/journal.pone.0123703

Ejemplares similares

Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials
por: He, Lingling, et al.
Publicado: (2016)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial
por: Linz, Peter E., et al.
Publicado: (2014)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023)

Decreased risk of Parkinson’s disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis
por: Zhu, Yueli, et al.
Publicado: (2019)

CML/RAGE signal induces calcification cascade in diabetes
por: Wang, Zhongqun, et al.
Publicado: (2016)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing the Effects of Biguanides (Metformin) and Thiazolidinediones on Glucose Tolerance and Insulin Sensitivity in Patients With Type II Diabetes Mellitus
por: Zaki, Hany A, et al.
Publicado: (2023)

Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis
por: Xu, Chunmei, et al.
Publicado: (2018)

Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
por: Susilawati, Elis, et al.
Publicado: (2023)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023)

Different Effects of Thiazolidinediones on In-Stent Restenosis and Target Lesion Revascularization after PCI: A Meta-Analysis of Randomized Controlled Trials
por: Zhou, Xinbin, et al.
Publicado: (2017)

Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
por: Liu, Yang, et al.
Publicado: (2018)

Factors Associated with Results and Conclusions of Trials of Thiazolidinediones
por: Rattinger, Gail, et al.
Publicado: (2009)

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011)

The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease
por: Colca, Jerry R., et al.
Publicado: (2021)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143
por: Song, Juan, et al.
Publicado: (2019)

Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats
por: Lee, Mi Young, et al.
Publicado: (2007)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
por: Mazzone, Peter J, et al.
Publicado: (2012)

Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation
por: Lee, Ji-Yeon, et al.
Publicado: (2018)

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
por: Behzad, Molavi, et al.
Publicado: (2007)

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
por: Alemán-González-Duhart, D., et al.
Publicado: (2016)

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case–control study
por: Chang, Shen-Shong, et al.
Publicado: (2013)

Risk of Fracture with Thiazolidinediones: An Individual Patient Data Meta-Analysis
por: Bazelier, Marloes T., et al.
Publicado: (2013)

Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis
por: Wang, Wen, et al.
Publicado: (2017)

DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
por: Wong, Carlos K H, et al.
Publicado: (2020)

Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
por: Lecka-Czernik, Beata
Publicado: (2010)

Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhong, Linda, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j7bm79k0unue078gi2dskpv3nc